<unk> (tablet) is a platelet aggregation inhibitor that is FDA approved for the treatment of postoperative thromboembolic complications of cardiac valve replacement.   Common adverse reactions include chest pain, electrocardiogram abnormalities, flushing, rash, abdominal discomfort, dizziness, headache, and dyspnea.
Dipyridamole 
Temocapril
Gadoxetate
Boldenone
Colestilan
Cetrorelix
Ticlopidine
Ramipril